PANACEA LIFE SCIENCES HOLDINGS, INC.
PublicBiotech · Greenwood Village, CO
Financials
FY2014–FY2023 · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 2 earlier years are in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Jun 11, 2024| Class | Outstanding | Votes / share | Converts | As converted | Last price |
|---|---|---|---|---|---|
| Series N-7 Convertible Preferrpreferred | 3,853,000 | — | 100 × Common Stock | 56.5% | — |
| Series Dpreferred | 1,628,126 | — | 162.813 × Common Stock | 38.9% | — |
| Series B-2 Preferred Stockpreferred | 6,000,000 | — | 1 × common stock | 0.88% | — |
| Series C Preferred Stockpreferred | 1,000,000 | — | 2.29 × Common Stock | 0.34% | — |
| Series B-1 Preferred Stockpreferred | 1,500,000 | — | 1 × common stock | 0.22% | — |
| Series C-1 Preferred Stockpreferred | 10,000 | — | 106.49 × Common Stock | 0.16% | — |
| Series C-2 Convertible Preferrpreferred | 100 | — | — | 0% | — |
| Common Stock | 20,261,288 | 1 | — | 2.97% | — |
| Total | 34,252,514 | 681,496,366.438 as converted | 100% |
Principal holders% as the filing states it, Jun 11, 2024
- J&N Real Estate Company LLC7,297,627 Common Stock41.4%of
- Leslie Buttorff1,359,899 Common Stock7.71%of
- Nicholas J Cavarra796,957 Common Stock4.52%of
- Lawrence J. Wert607,868 Common Stock3.45%of
- Nathan Berman67,749 Common Stock0.38%of
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. “As converted” counts each class in the shares it converts into. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
5 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 55 filings on EDGAR- Form 1-AJun 11, 20240001493152-24-023494EDGAR
- Form 10-QMay 6, 20240001493152-24-017858EDGAR
- Form 10-KApr 1, 20240001493152-24-012107EDGAR
- Form 10-QNov 14, 20230001493152-23-041041EDGAR
- Form 10-QAug 15, 20230001493152-23-028898EDGAR
- Form 10-QMay 12, 20230001493152-23-016537EDGAR
- Form 10-KMar 30, 20230001493152-23-009742EDGAR
- Form 10-QNov 14, 20220001493152-22-031530EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.